Echinacea

Echinacea refers to a genus of herbaceous flowering plants in the Asteraceae family, most notably Echinacea purpurea, which are widely used as dietary supplements for their purported immunomodulatory effects (NCCIH, 2020). It is not a single molecular target but a complex mixture of bioactive phytochemicals, including alkamides, caffeic acid derivatives (such as echinacoside), and polysaccharides (Barnes et al., 2005). Pharmacologically, certain alkamides in Echinacea have been identified as ligands for the Cannabinoid receptor type 2 (CB2), which may explain some of its anti-inflammatory properties (Raduner et al., 2006). Additionally, the extract is thought to stimulate the innate immune system by increasing phagocytic activity and altering cytokine production profiles (Zhai et al., 2007). While commonly used to prevent or treat upper respiratory tract infections like the common cold, clinical evidence regarding its efficacy remains inconsistent across various trials (David and Cunningham, 2019). Because it is a botanical product containing numerous constituents, it does not meet the criteria for a discrete therapeutic target in the conventional pharmacological sense.

Other names

Purple coneflowerEchinacea purpureaEchinacea angustifoliaEchinacea pallidaAmerican coneflower

Echinacea acts as a multi-component botanical extract rather than a single-target drug; its primary mechanisms include the activation of Cannabinoid receptor type 2 (CB2) by alkylamides, stimulation of macrophage phagocytosis, and the modulation of pro-inflammatory cytokines such as TNF-alpha and IL-1 (Raduner et al., 2006; Zhai et al., 2007).